NuVasive Inc (NUVA):製品パイプライン分析

◆英語タイトル:NuVasive Inc (NUVA) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010037
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月26日
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches. MAS platform combines three product categories, namely, MaXcess retractors, its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company’s products find application in spine fusion surgery, including biologics used to aid in the spinal fusion process. NuVasive is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NuVasive Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
NuVasive Inc Company Overview 6
NuVasive Inc Company Snapshot 6
NuVasive Inc Pipeline Products and Ongoing Clinical Trials Overview 6
NuVasive Inc – Pipeline Analysis Overview 9
Business Description 9
NuVasive Inc – Key Facts 10
NuVasive Inc – Major Products and Services 11
NuVasive Inc Pipeline Products by Development Stage 12
NuVasive Inc Ongoing Clinical Trials by Trial Status 16
NuVasive Inc Pipeline Products Overview 18
Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument 18
Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument Product Overview 18
Armada System 19
Armada System Product Overview 19
AttraX Putty 20
AttraX Putty Product Overview 20
AttraX Putty Clinical Trial 21
Cerpass Cervical Total Disc Replacement System 22
Cerpass Cervical Total Disc Replacement System Product Overview 22
COALESCE Posterior Lumbar Interbody Fusion Device 23
COALESCE Posterior Lumbar Interbody Fusion Device Product Overview 23
COALESCE Transforaminal Lumbar Interbody Fusion Device 24
COALESCE Transforaminal Lumbar Interbody Fusion Device Product Overview 24
COHERE Cervical Interbody Fusion Device – Multiple Footprint Configuration 25
COHERE Cervical Interbody Fusion Device – Multiple Footprint Configuration Product Overview 25
COHERE Cervical Interbody Fusion Device – Multiple Footprint Configuration Clinical Trial 26
COHERE Cervical Interbody Fusion Device – Multiple Height Configuration 27
COHERE Cervical Interbody Fusion Device – Multiple Height Configuration Product Overview 27
COHERE Cervical Interbody Fusion Device – Multiple Height Configuration Clinical Trial 28
MAS-PCF 29
MAS-PCF Product Overview 29
MAS-TLIF 30
MAS-TLIF Product Overview 30
NuVasive Reline System 31
NuVasive Reline System Product Overview 31
PRECICE OPTY-LINE System 32
PRECICE OPTY-LINE System Product Overview 32
PRECICE OPTY-LINE System Clinical Trial 33
XL TDR 34
XL TDR Product Overview 34
NuVasive Inc – Key Competitors 35
NuVasive Inc – Key Employees 36
NuVasive Inc – Key Employee Biographies 37
NuVasive Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 40
NuVasive Inc, Recent Developments 40
Dec 21, 2017: NuVasive Comments On Expected Impact Of U.S. Tax Reform 40
Dec 14, 2017: NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform 40
Oct 25, 2017: NuVasive Unveils Latest Innovation At NASS 2017 41
Oct 24, 2017: NuVasive Reports Third Quarter 2017 Financial Results 42
Oct 23, 2017: NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure 43
Oct 18, 2017: NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Portfolio 44
Oct 16, 2017: NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures 44
Sep 13, 2017: NuVasive Announces Commercial Launch Of LessRay System Designed to Significantly Reduce Radiation Exposure for Surgeons, Operating Room Staff and Patients 45
Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 46
Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 47
Appendix 48
Methodology 48
About GlobalData 50
Contact Us 50
Disclaimer 51

List of Tables
NuVasive Inc Pipeline Products and Ongoing Clinical Trials Overview 6
NuVasive Inc Pipeline Products by Equipment Type 6
NuVasive Inc Pipeline Products by Indication 7
NuVasive Inc Ongoing Clinical Trials by Trial Status 7
NuVasive Inc, Key Facts 10
NuVasive Inc, Major Products and Services 11
NuVasive Inc Number of Pipeline Products by Development Stage 12
NuVasive Inc Pipeline Products Summary by Development Stage 13
NuVasive Inc Ongoing Clinical Trials by Trial Status 16
NuVasive Inc Ongoing Clinical Trials Summary 17
Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument - Product Status 18
Adjustable Drill-Tap-Screw (DTS) Guide Surgical Instrument - Product Description 18
Armada System - Product Status 19
Armada System - Product Description 19
AttraX Putty - Product Status 20
AttraX Putty - Product Description 20
AttraX Putty - A Randomized Controlled Trial of AttraX Putty vs. Autograft in Instrumented Posterolateral Spinal Fusion 21
Cerpass Cervical Total Disc Replacement System - Product Status 22
Cerpass Cervical Total Disc Replacement System - Product Description 22
COALESCE Posterior Lumbar Interbody Fusion Device - Product Status 23
COALESCE Posterior Lumbar Interbody Fusion Device - Product Description 23
COALESCE Transforaminal Lumbar Interbody Fusion Device - Product Status 24
COALESCE Transforaminal Lumbar Interbody Fusion Device - Product Description 24
COHERE Cervical Interbody Fusion Device - Multiple Footprint Configuration - Product Status 25
COHERE Cervical Interbody Fusion Device - Multiple Footprint Configuration - Product Description 25
COHERE Cervical Interbody Fusion Device - Multiple Footprint Configuration - Comparison of Outcomes After ACDF Using Allograft Fusion Versus PEEK Fusion: A Prospective Clinical Trial 26
COHERE Cervical Interbody Fusion Device - Multiple Height Configuration - Product Status 27
COHERE Cervical Interbody Fusion Device - Multiple Height Configuration - Product Description 27
COHERE Cervical Interbody Fusion Device - Multiple Height Configuration - Comparison of Outcomes After ACDF Using Allograft Fusion Versus PEEK Fusion: A Prospective Clinical Trial 28
MAS-PCF - Product Status 29
MAS-PCF - Product Description 29
MAS-TLIF - Product Status 30
MAS-TLIF - Product Description 30
NuVasive Reline System - Product Status 31
NuVasive Reline System - Product Description 31
PRECICE OPTY-LINE System - Product Status 32
PRECICE OPTY-LINE System - Product Description 32
PRECICE OPTY-LINE System - Clinical Evaluation of Nuvasive PRECICE OPTY-LINE System in Europe 33
XL TDR - Product Status 34
XL TDR - Product Description 34
NuVasive Inc, Key Employees 36
NuVasive Inc, Key Employee Biographies 37
NuVasive Inc, Other Locations 38
NuVasive Inc, Subsidiaries 38
Glossary 49

★海外企業調査レポート[NuVasive Inc (NUVA):製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Macquarie Infrastructure Corporation:企業のM&A・事業提携・投資動向
    Macquarie Infrastructure Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Infrastructure Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Allied Irish Banks, Plc:戦略・SWOT・企業財務分析
    Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report Summary Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • New World Development Co Ltd (17):企業の財務・戦略的SWOT分析
    New World Development Co Ltd (17) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Columbia Banking System Inc:企業の戦略・SWOT・財務情報
    Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report Summary Columbia Banking System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pennant International Group plc (PEN):企業の財務・戦略的SWOT分析
    Summary Pennant International Group plc (Pennant) is a technology company that offers information services, training systems, and software services to its customers. The company offers supportability engineering software products, generic training equipment and LSAR software. Pennant generic trainin …
  • RussNeft Oil Co (RNFT):石油・ガス:M&Aディール及び事業提携情報
    Summary RussNeft Oil Company (RussNeft) is an oil and gas company that produces, refines and distributes crude oil, gas and petroleum products. The company operates through its business divisions such as geologic exploration and reserves, production, marketing, research center, transport and gas pro …
  • Molex LLC:医療機器:M&Aディール及び事業提携情報
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Red Electrica Corporacion, SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion, SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red E …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Domain Therapeutics SA-製薬・医療分野:企業M&A・提携分析
    Summary Domain Therapeutics SA (Domain Therapeutics) is a biopharmaceutical company that discovers and develops innovative therapeutics for the treatment of Central Nervous System (CNS) diseases and cancer by using transmembrane and G Protein-Coupled Receptor (GPCR) platform. Its pipeline consists o …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Caterpillar Inc.:企業の戦略・SWOT・財務情報
    Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report Summary Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Exxon Mobil Corp (XOM):企業の財務・戦略的SWOT分析
    Exxon Mobil Corp (XOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. It develops macrophage which is based on the recent und …
  • Golden Star Resources Ltd:企業の戦略・SWOT・財務情報
    Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Star Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Alpiq Holding AG (ALPH)-エネルギー分野:企業M&A・提携分析
    Summary Alpiq Holding AG (Alpiq) is an independent energy services company. The company produces electricity; and carries out energy trading and energy sales. It generates energy from hydro, nuclear, coal, natural gas, wind, and solar sources. Alpiq offers energy services for buildings and plants, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆